Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Nguyen, Christelle ^a   Bérezné, Alice ^a   Baubet, Thierry ^b   Mestre Stanislas, Caroline ^a   Rannou, François ^a   Papelard, Agathe ^a   Morell Dubois, Sandrine ^c   Revel, Michel ^a   Guillevin, Loïc ^a   Poiraudeau, Serge ^a   Mouthon, Luc ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; ARTICLE; BIVARIATE ANALYSIS; BODY MASS; CALCINOSIS; CLINICAL FEATURE; DEPRESSION; DISABILITY; DISEASE DURATION; ECHOCARDIOGRAPHY; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; QUALITY OF LIFE; SCLERODERMA; SELF REPORT; SEX DIFFERENCE; SYMPTOM; SYSTEMIC SCLEROSIS; DEMOGRAPHY; MIDDLE AGED; PATHOLOGY; SEXUAL DEVELOPMENT;

ANXIETY; DEMOGRAPHY; DEPRESSION; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SCLERODERMA, SYSTEMIC; SELF REPORT; SEX CHARACTERISTICS;

EID: 79952502651     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017551     Document Type: Article

References (55)

1. Tamby MC, Chanseaud Y, Guillevin L, Mouthon L, (2003) New insights into the pathogenesis of systemic sclerosis. Autoimmun Rev 2: 152-157.
2. Steen VD, Medsger TA Jr, (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43: 2437-2444.
3. Poole JL, Steen VD, (1991) The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 4: 27-31.
4. Angelopoulos NV, Drosos AA, Moutsopoulos HM, (2001) Psychiatric symptoms associated with scleroderma. Psychother Psychosom 70: 145-150.
5. Benrud-Larson LM, Haythornthwaite JA, Heinberg LJ, Boling C, Reed J, et al. (2002) The impact of pain and symptoms of depression in scleroderma. Pain 95: 267-275.
6. Haythornthwaite JA, Heinberg LJ, McGuire L, (2003) Psychologic factors in scleroderma. Rheum Dis Clin North Am 29: 427-439.
7. Hyphantis TN, Tsifetaki N, Pappa C, Voulgari PV, Siafaka V, et al. (2007) Clinical features and personality traits associated with psychological distress in systemic sclerosis patients. J Psychosom Res 62: 47-56.
8. Legendre C, Allanore Y, Ferrand I, Kahan A, (2005) Evaluation of depression and anxiety in patients with systemic sclerosis. Joint Bone Spine 72: 408-411.
9. Matsuura E, Ohta A, Kanegae F, Haruda Y, Ushiyama O, et al. (2003) Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma. J Rheumatol 30: 1782-1787.
10. Roca RP, Wigley FM, White B, (1996) Depressive symptoms associated with scleroderma. Arthritis Rheum 39: 1035-1040.
11. Straszecka J, Kucharz EJ, Jonderko G, Kotulska A, Bednarczyk-Kaluzny M, et al. (1996) Depression and anxiety in patients with systemic sclerosis. Clin Rheumatol 15: 621.
12. Thombs BD, Hudson M, Taillefer SS, Baron M, (2008) Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthritis Rheum 59: 504-509.
13. Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J, (2008) Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 37: 223-235.
14. Oliver JE, Silman AJ, (2009) Why are women predisposed to autoimmune rheumatic diseases? Arthritis Res Ther 11: 252.
15. Simeon CP, Castro-Guardiola A, Fonollosa V, Armadans L, Clemente C, et al. (1996) Systemic sclerosis in men: clinical and immunological differences. Br J Rheumatol 35: 910-911.
16. Peters-Golden M, Wise RA, Schneider P, Hochberg M, Stevens MB, et al. (1984) Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis. Medicine (Baltimore) 63: 221-231.
17. Wynn J, Fineberg N, Matzer L, Cortada X, Armstrong W, et al. (1985) Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features. Am Heart J 110: 123-127.
18. Joven B, Almodovar R, Carreira PE, (2006) Gender differences in systemic sclerosis clinical expression and survival [abstract]. Ann Rheum Dis 65: 395.
19. Carreira PE, Carmona L, Joven BE, Allanore Y, Walker U, et al. (2009) Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database [abstract]. Ann Rheum Dis 68: 96.
20. Hudson M, Thombs B, Baron M, (2009) Time to diagnosis in systemic sclerosis: is sex a factor? Arthritis Rheum 61: 274-278.
21. (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23: 581-590.
22. LeRoy EC, Medsger TA Jr, (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28: 1573-1576.
23. Mouthon L, Rannou F, Bérezné A, Pagnoux C, Guilpain P, et al. (2008) Patient preference disability questionnaire in systemic sclerosis: a cross-sectional survey. Arthritis Rheum 59: 968-973.
24. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, et al. (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363: 1665-1672.
25. Evans C, McCarthy M, (1985) Prognostic uncertainty in terminal care: can the Karnofsky index help? Lancet 1: 1204-1206.
26. Nguyen C, Poiraudeau S, Mestre-Stanislas C, Rannou F, Bérezné A, et al. (2010) Employment status and socio-economic burden in systemic sclerosis: a cross-sectional survey. Rheumatology (Oxford) 49: 982-9.
27. Ware JE Jr, Sherbourne CD, (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: 473-483.
28. Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, et al. (2002) Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheum 46: 2410-2420.
29. Tugwell P, Bombardier C, Buchanan WW, Goldsmith CH, Grace E, et al. (1987) The MACTAR Patient Preference Disability Questionnaire-an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol 14: 446-451.
30. Nguyen C, Mouthon L, Mestre-Stanislas C, Rannou F, Bérezné A, et al. (2010) Sensitivity to Change in Systemic Sclerosis of the McMaster-Toronto Arthritis Patient Preference Disability Questionnaire (MACTAR): Shift in Patient Priorities Over Time. J Rheumatol 37: 359-364.
31. Duruoz MT, Poiraudeau S, Fermanian J, Menkes CJ, Amor B, et al. (1996) Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol 23: 1167-1172.
32. Rannou F, Poiraudeau S, Berezne A, Baubet T, Le-Guern V, et al. (2007) Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey. Arthritis Rheum 57: 94-102.
33. Mouthon L, Rannou F, Berezne A, Pagnoux C, Arene JP, et al. (2007) Development and validation of a scale for mouth handicap in systemic sclerosis: the Mouth Handicap in Systemic Sclerosis scale. Ann Rheum Dis 66: 1651-1655.
34. Zigmond AS, Snaith RP, (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67: 361-370.
35. Bjelland I, Dahl AA, Haug TT, Neckelmann D, (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52: 69-77.
36. Honarmand K, Feinstein A, (2009) Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Mult Scler 15: 1518-1524.
37. Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, et al. (2008) The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) 47: 1185-1192.
38. Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, et al. (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48: 2246-2255.
39. Al-Dhaher FF, Pope JE, Ouimet JM, (2010) Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum 39: 269-277.
40. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, et al. (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81: 139-153.
41. Hesselstrand R, Scheja A, Akesson A, (1998) Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 57: 682-686.
42. Gaultier JB, Hot A, Cathebras P, Grange C, Ninet J, et al. (2008) [Systemic sclerosis in men]. Rev Med Interne 29: 181-186.
43. Assassi S, Del Junco D, Sutter K, McNearney TA, Reveille JD, et al. (2009) Clinical and genetic factors predictive of mortality in early systemic sclerosis. Arthritis Rheum 61: 1403-1411.
44. Robertson LP, Marshall RW, Hickling P, (2003) Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline. Ann Rheum Dis 62: 267-269.
45. Boulman N, Slobodin G, Rozenbaum M, Rosner I, (2005) Calcinosis in rheumatic diseases. Semin Arthritis Rheum 34: 805-812.
46. Black CM, (1993) The aetiopathogenesis of systemic sclerosis. J Intern Med 234: 3-8.
47. Mouthon L, Mestre-Stanislas C, Bérezné A, Rannou F, Guilpain P, et al. (2010) Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis. Ann Rheum Dis 69: 214-217.
48. Steen VD, Medsger TA, (2007) Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 66: 940-944.
49. Azad N, Gondal M, Abbas N, (2008) Frequency of depression and anxiety in patients attending a rheumatology clinic. J Coll Physicians Surg Pak 18: 569-573.
50. Waheed A, Hameed K, Khan AM, Syed JA, Mirza AI, (2006) The burden of anxiety and depression among patients with chronic rheumatologic disorders at a tertiary care hospital clinic in Karachi, Pakistan. J Pak Med Assoc 56: 243-247.
51. Ramjeet J, Koutantji M, Barrett EM, Scott DG, (2005) Coping and psychological adjustment in recent-onset inflammatory polyarthritis: the role of gender and age. Rheumatology (Oxford) 44: 1166-1168.
52. McLean CP, Anderson ER, (2009) Brave men and timid women? A review of the gender differences in fear and anxiety. Clin Psychol Rev 29: 496-505.
53. Hudson M, Thombs BD, Steele R, Watterson R, Taillefer S, et al. (2008) Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II. Arthritis Rheum 59: 279-284.
54. Georges C, Chassany O, Mouthon L, Tiev K, Toledano C, et al. (2005) Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol 24: 3-10.
55. Mestre-Stanislas C, Poiraudeau S, Bérezné A, Rannou F, Pagnoux C, et al. (2010) Differences in patients with systemic sclerosis recruited from associations and tertiary care settings. Presse Med.